Connect Sign In
Effective August 15, 2022, ARUP Laboratories will consolidate the existing molecular Herpes Simplex Virus (HSV) test options into a single test option, Herpes Simplex Virus (HSV-1/HSV-2) Subtype by PCR. This test not only detects HSV but also identifies the subtype (HSV-1 or HSV-2), which is an important factor for clinical decisions regarding treatment. This change aligns with recent guidelines from the CDC.
This change will be published in the August 15, 2022, Quarterly Hotline.
Available Test Option
|
Herpes Simplex Virus (HSV-1/HSV-2) Subtype by PCR |
Inactivated Tests
|
Herpes Simplex Virus by PCR |
|
|
Herpes Simplex Virus (HSV) by PCR with Reflex to HSV (HSV-1/HSV-2) Subtype by PCR |
Advantages of HSV Subtyping
- Recurrence and subclinical viral shedding occur more frequently in cases caused by HSV-2 than in cases caused by HSV-1.
- Sexually Transmitted Infections Treatment Guidelines, 2021, Genital Herpes. CDC. Updated July 22, 2021. Accessed July 5, 2022.
- Herpes Simplex Virus - HSV on ARUP Consult
Additional Information
If you have additional questions, please contact ARUP Client Services and use keyword: HSV
Contact ARUP Client Services
call 1-800-522-2787 | online chat aruplab.com | email clientservices@aruplab.com
